I consulted with my colleague who had made the DMT, David Nichols, Ph.D., at Purdue University in Indiana. He agreed that I needed to switch to the intravenous route. Reflecting upon our mutual anxiety about this change in plans, he added dryly, “I’m glad it’s you and not me.” It was time to consult with Dr. W., the physician at the U.S. Food and Drug Administration (FDA) who, after helping guide the project through the two-year regulatory process, was now overseeing its performance. When I asked his opinion, he laughed and said, “You are the only research scientist in the world giving DMT.
...more
